- Home
- IMUX vs KVHI Comparison
IMUX vs KVHI Comparison
Compare IMUX & KVHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- KVHI
- Stock Information
- Founded
- IMUX 2016
- KVHI 1978
- Country
- IMUX United States
- KVHI United States
- Employees
- IMUX N/A
- KVHI N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- KVHI Radio And Television Broadcasting And Communications Equipment
- Sector
- IMUX Health Care
- KVHI Technology
- Exchange
- IMUX Nasdaq
- KVHI Nasdaq
- Market Cap
- IMUX 90.3M
- KVHI 105.7M
- IPO Year
- IMUX N/A
- KVHI 1996
- Fundamental
- Price
- IMUX $0.98
- KVHI $5.05
- Analyst Decision
- IMUX Strong Buy
- KVHI
- Analyst Count
- IMUX 6
- KVHI 0
- Target Price
- IMUX $13.20
- KVHI N/A
- AVG Volume (30 Days)
- IMUX 661.4K
- KVHI 41.0K
- Earning Date
- IMUX 05-07-2025
- KVHI 05-05-2025
- Dividend Yield
- IMUX N/A
- KVHI N/A
- EPS Growth
- IMUX N/A
- KVHI N/A
- EPS
- IMUX N/A
- KVHI N/A
- Revenue
- IMUX N/A
- KVHI $113,828,000.00
- Revenue This Year
- IMUX N/A
- KVHI $4.22
- Revenue Next Year
- IMUX N/A
- KVHI $13.27
- P/E Ratio
- IMUX N/A
- KVHI N/A
- Revenue Growth
- IMUX N/A
- KVHI N/A
- 52 Week Low
- IMUX $0.83
- KVHI $4.17
- 52 Week High
- IMUX $2.11
- KVHI $6.16
- Technical
- Relative Strength Index (RSI)
- IMUX 45.24
- KVHI 47.32
- Support Level
- IMUX $0.86
- KVHI $4.80
- Resistance Level
- IMUX $1.01
- KVHI $5.14
- Average True Range (ATR)
- IMUX 0.09
- KVHI 0.25
- MACD
- IMUX -0.01
- KVHI 0.01
- Stochastic Oscillator
- IMUX 42.53
- KVHI 34.29
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About KVHI KVH Industries Inc.
KVH Industries Inc provide integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. The Company operates in a number of geographic areas, including internationally. The Revenues are generated from international locations, mainly consisting of Singapore, Canada, European Union countries and other European countries, countries in Africa, Asia/Pacific and the Middle East, and India.